Parkinson’s UK to inject £1m into drug development by Anna Smith | Jul 1, 2019 | News | 0 The charity is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells. Read More
Addex joins UK drug and brain research initiative by Selina McKee | Sep 20, 2018 | News | 0 Swiss group Addex Therapeutics has joined a UK-based initiative established to study the role of the D1 receptor, the main dopamine receptor, in human brain function. Read More